Picture of Xintela AB logo

XINT Xintela AB Cashflow Statement

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Annual cashflow statement for Xintela AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

R2021
December 31st
R2022
December 31st
2023
December 31st
2024
December 31st
2025
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:Interim ReportInterim ReportARSARSPRESS
Standards:
SAS
SAS
SAS
SAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-59.6-69.1-57.2-39.4-46.7
Depreciation
Non-Cash Items0-3.055.821.89-1.43
Other Non-Cash Items
Changes in Working Capital1.21-5.23-5.46-3.695.88
Change in Accounts Receivable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities-54.9-73.1-53.1-40.7-41.6
Capital Expenditures-2.430-0.10400
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items0.0530.224000
Sale of Fixed Assets
Sale/Maturity of Investment
Cash from Investing Activities-2.380.224-0.10400
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities34.770.451.850.148.5
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-22.6-2.8-0.5348.876.53